Patents by Inventor Stephen Eliot Zweig
Stephen Eliot Zweig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20160325112Abstract: An active material, suitable for implantable medical devices. The active material is a mixture, composite, or aggregate of upconverting particles and photocatalytic particles embedded in an at least infrared light conducting and gas permeable support material. The upconverting particles convert longer wavelength light into shorter wavelength light, which in turn powers the photocatalytic materials to produce cytotoxic chemicals. When embedded into an implantable medical device in a desired body location, and exposed to red or infrared light, this active material can produce cytotoxic chemicals that in turn exert a cytotoxic effect on unwanted cells, such as cancer or microbial cells, as well as perform other functions.Type: ApplicationFiled: May 13, 2016Publication date: November 10, 2016Inventor: Stephen Eliot Zweig
-
Patent number: 8190374Abstract: The present invention consists of a time-temperature indicator device that has at least one parameter set to warn when a therapeutic protein drug has had a thermal history associated with increased risk of unwanted immunological activity. The indicator device is designed to remain with the drug as the drug travels throughout different links of the cold chain. In a preferred embodiment, the indicator device remains associated with the therapeutic protein from the time of manufacture up until the final few minutes before the drug is used. In alternate forms of the invention, additional parameters, including motion, light, color and turbidity may also be monitored. Novel methods for determining therapeutic protein time-temperature immunological risk parameters, and programming or adjusting the indicator device, are also disclosed.Type: GrantFiled: May 28, 2007Date of Patent: May 29, 2012Inventor: Stephen Eliot Zweig
-
Patent number: 8118991Abstract: The invention discloses a device and method by which dry reagent enzyme based electrochemical biosensors, which are in a relatively mature form due to the extensive amount of development pioneered by the blood glucose monitoring industry, may be simply adapted to perform tests for blood coagulation, enzymatic activity, or immunochemical assays for antigens present in a fluid sample. In particular, the utility of combining apoenzyme based dry reagent electrochemical biosensors with apoenzyme reactivation technology is taught. This combination creates a novel combination test technology capable of detecting a wide range of different analytes, and operating in a wide variety of wet or dry, in vivo or in vitro environments.Type: GrantFiled: January 22, 2007Date of Patent: February 21, 2012Inventor: Stephen Eliot Zweig
-
Publication number: 20110054305Abstract: Implantable medical devices, such as catheters and stents, which contain light upconverting materials as part of their construction, are disclosed. Such upconverting materials, often rare earth compounds, can convert longer wavelength light, such as light from the 600-800 nm region, which penetrates the body tissue easily, but which is too low energy to induce many chemical reactions, into shorter wavelength light, such as light above 500 nm, which penetrates only a small distance through the body tissues, but which contains enough energy to induce a greater variety of chemical reactions, including conversion of drugs such as psorlens from an inactive to an active form, activation of cytotoxic or antimicrobial photocatalysts such as TiO2, and conversion of non-target molecules to target molecules for other drug and biotherapeutic systems. Such implantable devices can potentially exert their therapeutic effects for years after administration.Type: ApplicationFiled: August 30, 2010Publication date: March 3, 2011Inventor: Stephen Eliot Zweig
-
Patent number: 7758744Abstract: Diagnostic dry reagent tests capable of reacting with a single drop of whole blood and reporting both glucose and light-scattering analytes, such as chylomicrons, are taught. Such dry reagent tests may employ electrochemical detection methodologies, optical detection methodologies, or both methodologies. These tests alert diabetics to excessive levels of postprandial lipemia caused by meals with excessive amounts of fat, and thus can help reduce the risk of cardiovascular complications in diabetic patients.Type: GrantFiled: October 31, 2005Date of Patent: July 20, 2010Inventor: Stephen Eliot Zweig
-
Patent number: 7564364Abstract: This invention covers improved electronic time-temperature indicators with an RFID output, and other devices and methods by which the thermal history of a complex material, which may not obey a simple exponential Arrhenius law degradation equation, may be monitored, and the subsequent fitness for use of the tracked material may be quickly ascertained. In particular, the invention discloses a rapidly reprogrammable electronic time-temperature RFID tag that may be easily customized with the thermal time-temperature stability profile of an arbitrary material, using electronic data transfer methods. Using this device, a single, low-cost, generic time-temperature tag may be mass-produced, and then subsequently programmed to mimic the stability characteristics of nearly any material of interest.Type: GrantFiled: September 1, 2006Date of Patent: July 21, 2009Inventor: Stephen Eliot Zweig
-
Patent number: 7291698Abstract: Novel synthetic enzyme substrates, enhanced to have improved enzymatic specificity, are disclosed. These synthetic enzyme substrates consist of a substrate peptide that has had its specificity further improved by additional synthetic moieties, selected by combinatorial chemistry techniques, that act to sterically block non-target enzymes. These “steric restrictor” moieties may be labeled to produce a detectable signal upon enzymatic reaction. These novel substrates are particularly useful for improved enzyme substrate microarrays. Specific applications for improved protease substrate microarrays are discussed.Type: GrantFiled: September 3, 2002Date of Patent: November 6, 2007Inventor: Stephen Eliot Zweig
-
Patent number: 7288368Abstract: A membrane receptor reagent and assay is disclosed in which liposomes are bound to an evanescent wave emitting surface. Membrane receptors on the liposome's fluid lipid bilayer membrane are labeled with a fluorescent or luminescent moiety. These membrane receptors are free to diffuse randomly throughout the liposome surface, and thus tend to redistribute according to externally applied forces. The evanescent wave-emitting surface additionally contains reagents that reversibly bind to the membrane receptors, tending to bring them closer to region of high evanescent wave intensity. Test analytes that disrupt or promote the association between the membrane receptors and the surface reagents act to change the average distance between the membrane receptors and the evanescent wave emitting surface, resulting in a change in the fluorescent or luminescent signal.Type: GrantFiled: July 6, 2004Date of Patent: October 30, 2007Inventor: Stephen Eliot Zweig
-
Patent number: 7174238Abstract: The invention is a computerized mobile robot with an onboard internet web server, and a capability of establishing a first connection to a remote web browser on the internet for robotic control purposes, and a capability of establishing a second short range bi-directional digital radio connection to one or more nearby computerized digital radio equipped devices external to the robot. The short-range bi-directional digital radio connection will typically have a maximum range of about 300 feet. In a preferred embodiment, this short-range wireless digital connection will use the 2.4 gHz band and digital protocols following the IEEE 802.11, 802.15, or other digital communications protocol.Type: GrantFiled: September 2, 2003Date of Patent: February 6, 2007Inventor: Stephen Eliot Zweig
-
Patent number: 7166208Abstract: The invention discloses a methods in which dry reagent enzyme based electrochemical biosensors, which are in a relatively mature form due to the extensive amount of development pioneered by the blood glucose monitoring industry, may be simply adapted to perform tests for blood coagulation, enzymatic activity, or immunochemical assays for antigens present in a fluid sample. In particular, the utility of combining apoenzyme based dry reagent electrochemical biosensors with apoenzyme reactivation technology is taught. This combination creates a novel combination dry reagent test technology capable of detecting a wide range of different analytes.Type: GrantFiled: February 17, 2005Date of Patent: January 23, 2007Inventor: Stephen Eliot Zweig
-
Patent number: 7102526Abstract: This invention covers improved electronic time-temperature indicators with a visual output, and other devices and methods by which the thermal history of a complex material, which may not obey a simple exponential Arrhenius law degradation equation, may be monitored, and the subsequent fitness for use of the tracked material may be quickly ascertained. In particular, the invention discloses a rapidly reprogrammable electronic time-temperature tag that may be easily customized with the thermal time-temperature stability profile of an arbitrary material, using electronic data transfer methods. Using this device, a single, low-cost, generic time-temperature tag may be mass-produced, and then subsequently programmed to mimic the stability characteristics of nearly any material of interest.Type: GrantFiled: April 14, 2004Date of Patent: September 5, 2006Inventor: Stephen Eliot Zweig
-
Patent number: 7096090Abstract: The invention is a computerized mobile robotic router with an onboard internet web server, and a capability of establishing a first connection to a remote web browser on the internet for robotic control purposes, and a capability of establishing a second short range bi-directional digital radio connection to one or more nearby computerized digital radio equipped computers or devices external to the robot. The short-range bi-directional digital radio connection will typically have a maximum range of about 300 feet. In a preferred embodiment, this short-range wireless digital connection will use the 2.4 gHz band and digital protocols following the IEEE 802.11, 802.15, or other digital communications protocol.Type: GrantFiled: November 3, 2003Date of Patent: August 22, 2006Inventor: Stephen Eliot Zweig
-
Patent number: 6984307Abstract: Diagnostic dry reagent tests capable of reacting with a single drop of whole blood and reporting both glucose and beta-hydroxybutyrate levels are taught. Such dry reagent tests may employ electrochemical detection methodologies, optical detection methodologies, or both methodologies. These tests help facilitate the early detection of the onset of ketoacidosis in diabetes.Type: GrantFiled: October 3, 2002Date of Patent: January 10, 2006Inventor: Stephen Eliot Zweig
-
Patent number: 6950028Abstract: This invention covers electronic time-temperature indicators with a visual output, and other devices and methods by which the thermal history of a material may be monitored, and the subsequent fitness for use of the tracked material may be quickly ascertained. In particular, the invention discloses a rapidly reprogrammable electronic time-temperature tag that may be easily customized with the thermal time-temperature stability profile of an arbitrary material, using electronic data transfer methods. Using this device, a single, low-cost, generic time-temperature tag may be mass-produced, and then subsequently programmed to mimic the stability characteristics of nearly any material of interest.Type: GrantFiled: August 5, 2003Date of Patent: September 27, 2005Inventor: Stephen Eliot Zweig
-
Publication number: 20040241765Abstract: A membrane receptor reagent and assay is disclosed in which liposomes are bound to an evanescent wave emitting surface. Membrane receptors on the liposome's fluid lipid bilayer membrane are labeled with a fluorescent or luminescent moiety. These membrane receptors are free to diffuse randomly throughout the liposome surface, and thus tend to redistribute according to externally applied forces. The evanescent wave-emitting surface additionally contains reagents that reversibly bind to the membrane receptors, tending to bring them closer to region of high evanescent wave intensity. Test analytes that disrupt or promote the association between the membrane receptors and the surface reagents act to change the average distance between the membrane receptors and the evanescent wave emitting surface, resulting in a change in the fluorescent or luminescent signal.Type: ApplicationFiled: July 6, 2004Publication date: December 2, 2004Inventor: Stephen Eliot Zweig
-
Publication number: 20040212508Abstract: The present invention consists of a time-temperature indicator device that has at least one parameter set to warn when a therapeutic protein drug has had a thermal history associated with increased risk of unwanted immunological activity. The indicator device is designed to remain with the drug as the drug travels throughout different links of the cold chain. In a preferred embodiment, the indicator device remains associated with the therapeutic protein from the time of manufacture up until the final few minutes before the drug is used. In alternate forms of the invention, additional parameters, including motion, light, and turbidity may also be monitored. Novel methods for determining therapeutic protein time-temperature immunological risk parameters, and programming or adjusting the indicator device, are also disclosed.Type: ApplicationFiled: December 29, 2003Publication date: October 28, 2004Inventor: Stephen Eliot Zweig
-
Publication number: 20040212509Abstract: This invention covers improved electronic time-temperature indicators with a visual output, and other devices. and methods by which the thermal history of a complex material, which may not obey a simple exponential Arrhenius law degradation equation, may be monitored, and the subsequent fitness for use of the tracked material may be quickly ascertained. In particular, the invention discloses a rapidly reprogrammable electronic time-temperature tag that may be easily customized with the thermal time-temperature stability profile of an arbitrary material, using electronic data transfer methods. Using this device, a single, low-cost, generic time-temperature tag may be mass-produced, and then subsequently programmed to mimic the stability characteristics of nearly any material of interest.Type: ApplicationFiled: April 14, 2004Publication date: October 28, 2004Inventor: Stephen Eliot Zweig
-
Publication number: 20040212507Abstract: This invention covers electronic time-temperature indicators with a visual output, and other devices and methods by which the thermal history of a material may be monitored, and the subsequent fitness for use of the tracked material may be quickly ascertained. In particular, the invention discloses a rapidly reprogrammable electronic time-temperature tag that may be easily customized with the thermal time-temperature stability profile of an arbitrary material, using electronic data transfer methods. Using this device, a single, low-cost, generic time-temperature tag may be mass-produced, and then subsequently programmed to mimic the stability characteristics of nearly any material of interest.Type: ApplicationFiled: August 5, 2003Publication date: October 28, 2004Inventor: Stephen Eliot Zweig
-
Patent number: 6790632Abstract: A membrane receptor reagent and assay is disclosed in which liposomes are bound to an evanescent wave emitting surface. Membrane receptors on the liposome's fluid lipid bilayer membrane are labeled with a fluorescent or luminescent moiety. These membrane receptors are free to diffuse randomly throughout the liposome surface, and thus tend to redistribute according to externally applied forces. The evanescent wave-emitting surface additionally contains reagents that reversibly bind to the membrane receptors, tending to bring them closer to region of high evanescent wave intensity. Test analytes that disrupt or promote the association between the membrane receptors and the surface reagents act to change the average distance between the membrane receptors and the evanescent wave emitting surface, resulting in a change in the fluorescent or luminescent signal.Type: GrantFiled: May 23, 2003Date of Patent: September 14, 2004Inventor: Stephen Eliot Zweig
-
Publication number: 20040033624Abstract: A membrane receptor reagent and assay is disclosed in which liposomes are bound to an evanescent wave emitting surface. Membrane receptors on the liposome's fluid lipid bilayer membrane are labeled with a fluorescent or luminescent moiety. These membrane receptors are free to diffuse randomly throughout the liposome surface, and thus tend to redistribute according to externally applied forces. The evanescent wave-emitting surface additionally contains reagents that reversibly bind to the membrane receptors, tending to bring them closer to region of high evanescent wave intensity. Test analytes that disrupt or promote the association between the membrane receptors and the surface reagents act to change the average distance between the membrane receptors and the evanescent wave emitting surface, resulting in a change in the fluorescent or luminescent signal.Type: ApplicationFiled: May 23, 2003Publication date: February 19, 2004Inventor: Stephen Eliot Zweig